跳至主要内容
临床试验/NCT04957927
NCT04957927Unknown4 期

Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Usama Azhar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年12月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
Improvement in Day and Night time nasal symptoms score of Allergic Rhinitis

研究概览

简要总结

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

详细描述

Our study will compare the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age as in our population compliance with oral medication is better among patients, and is socially and culturally more acceptable.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
2 Years 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age:02 to 05 Years of Age
  • both genders will be included.
  • patients diagnosed with allergic rhinitis.

排除标准

  • patients older than 05 years of age
  • a positive history of HIV,TB,Immune deficiency.
  • any nasal structural abnormality i.e.polyps,deviated nasal septum.
  • history of frequent nasal bleeding,epistaxis.
  • concomitant asthma.

研究组 & 干预措施

Intranasal Fluticasone Propionate Group

Experimental

Intranasal Fluticasone Propionate 50mcg/actuation in each nostril 24 hourly

干预措施: Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age (Drug)

Montelukast Group

Experimental

Montelukast 4mg oral granule formulation 24 hourly

干预措施: Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age (Drug)

结局指标

主要结局

Improvement in Day and Night time nasal symptoms score of Allergic Rhinitis

时间窗: 2 months

Effectiveness will be assessed by noticing the Improvement in Day and Night time nasal symptoms score of Allergic Rhinitis.

次要结局

未报告次要终点

研究者

发起方
Usama Azhar
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Usama Azhar

Post Graduate Resident in Pediatrics(MD Pediatrics)

King Edward Medical University

研究点 (1)

Loading locations...

相似试验